BioSpace News Archive

Biotech Beach

Tentarix Biotherapeutics Completes Series B Financing Bringing Total Equity and Upfront Deal Consideration to $132 Million

Tentarix Biotherapeutics, a biotechnology company focused on leveraging its proprietary Tentacles™ platform to discover and develop multi-functional, conditional protein therapeutics, today announced it has raised $35 million in a Series B financing led by Amplitude Ventures with participation from Gilead Sciences, Inc., and founding investors Versant Ventures and Samsara BioCapital.

September 6, 2023
·
3 min read
Business

Convergent Therapeutics Expands Leadership Team with the Appointments of Neil Bander, MD. as Chief Scientific Officer, Eric M. Sullivan as Chief Financial Officer, and Dimitris Voliotis, MD. as Senior Vice President of Clinical Development

Convergent Therapeutics Inc. today announced the expansion of its leadership team with the appointments of Neil Bander, MD, as Chief Scientific Officer, Eric M. Sullivan as Chief Financial Officer, and Dimitris Voliotis , MD, as Senior Vice President of Clinical Development.

September 6, 2023
·
3 min read
Business

OncoResponse Announces Appointment of Carol Gallagher to Board of Directors

OncoResponse, a clinical-stage biotech company advancing immunotherapies derived from the immune systems of Elite Cancer Responders, announced the appointment of Carol Gallagher, Pharm.D., as an Independent Director to its Board of Directors.

September 6, 2023
·
2 min read